Relevate Health Group and Arteric Appoint Three New Members to Board of Directors
By: Relevate Health Group
Michael Darviche, Cynthia Schwalm and Christopher French will assist senior leadership with developing strategies for future expansion and growth.
"We are thrilled to have Mike, Cynthia and Chris join our Board. Their extensive knowledge of the healthcare industry and expertise in business consulting will be vital to the development of our strategic growth plan. This group has a strong track record of building businesses, especially ones that leverage data, technologies and digital. They bring invaluable experience for executing our strategic growth plan," said Jeff Spanbauer, Chief Executive Officer of Relevate.
Darviche, a long-time technology, digital and data executive, has led company transformations for Marsh Inc and Acxiom. He has served as CEO, GM, Chief Marketing,
Chief Strategy and Chief Digital Officer for VC backed and public companies. Today his firm, Bridge22, builds and leads organic and inorganic growth programs for high growth companies in product, marketing and M&A.
Schwalm is a senior life sciences executive with decades of strategic and operational leadership experience developing and expanding healthcare organizations in the pharmaceutical, start-up and bio-tech industries. Schwalm held senior leadership positions at Johnson & Johnson, Amgen, Eisai and Ipsen, and received numerous leadership awards and recognitions.
French is a seasoned healthcare and corporate development professional with more than 30 years of experience in successful M&A transactions. In addition to his M&A expertise, French held senior leadership positions at two healthcare technology businesses and has 25 years of Board experience across three private equity-backed companies.
Darviche stated, "I am a big fan of what Relevate and Arteric have built, and I see opportunities in healthcare marketing accelerating as we come out of Covid-19. Relevate has a very powerful suite of local content products powered by Arteric's machine learning and data science technology. Their multichannel digital marketing agency extends this to national campaigns as well. I see so many ways to expand on these assets."
"Relevate and Arteric have the capability to facilitate increased delivery of relevant communications between health care providers, their networked communities and patients. I look forward to working with the board and leadership team." said Schwalm.
French added, "I am very excited to work with Relevate, Arteric and the Board. I look forward to developing strategies to propel them into future expansion."
With support from Mountaingate Capital, experts in data-driven marketing services, Relevate completed a strategic combination with Arteric in December 2020 to form a next generation data & ML-driven agency serving the pharmaceutical, biotechnology and healthcare markets.
Account Email Address Account Phone Number Disclaimer Report Abuse